SCHEMBL4191820

SCHEMBL4191820

COc1ccccc1C=C(C#N)S(=O)(=O)Nc1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 4/20 0.51
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
LMNA P02545 5/20 0.50
PKM P14618 3/20 0.50
KMT2A Q03164 3/20 0.50
CDK2 P24941 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
RECQL P46063 2/20 0.42
MEN1 O00255 2/20 0.42
CYP1A2 P05177 1/20 0.42
GLA P06280 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4191815 1.00 ALDH1A1 (0.51) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL4191817 1.00 ALDH1A1 (0.51) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL4185249 0.90 KDM4E (0.51) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL4185240 0.90 KDM4E (0.51) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL4185243 0.90 KDM4E (0.51) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL4189424 0.89 KDM4E (0.50) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL4189415 0.89 KDM4E (0.50) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL4189421 0.89 KDM4E (0.50) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL4181472 0.86 CA12 (0.50) ALDH1A1KDM4ECA12CA1CA2
SCHEMBL4181477 0.86 CA12 (0.50) ALDH1A1KDM4ECA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 ALDH1A1 249/4885KDM4E 1688/4885CA12 2120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.